Human genetics and sleep behavior
Why we sleep remains one of the greatest mysteries in science.
In the past few years, great advances have been made to better understand this phenomenon. Human genetics has contributed significantly to this movement, as many features of sleep have been found to be heritable. Discoveries about these genetic variations that affect human sleep will aid us in understanding the underlying mechanism of sleep. Here we summarize recent discoveries about the genetic variations affecting the timing of sleep, duration of sleep and EEG patterns. To conclude, we also discuss some of the sleep-related neurological disorders such as Autism Spectrum Disorder (ASD) and Alzheimer's Disease (AD) and the potential challenges and future directions of human genetics in sleep research.
Introduction
The field of human genetics began to gain momentum as a powerful approach for defining the causes of diseases beginning in the 1980s. This approach continues to be fruitful nearly 3 decades later. Over the past 30 years, human genetics has revolutionized the field of biomedical research and medicine in general. The identification of genetic causes for diseases generated a dramatic paradigm shift in the process of studying disease pathophysiology. The great hope is that understanding of genetics and biology of specific diseases will lead to a more rational approach to devising better treatments.
Sleep is known to have a large impact on human health but remains a great mystery today. Studies of human behaviors, including sleep, are more challenging than studies of diseases because behavioral phenotypes are typically more complex and are generally subject to many environmental factors. Nonetheless, an opportunity arose in the late 1990s with identification of the first familial circadian phenotype (familial advanced sleep phase syndrome-FASP) that made it possible to begin genetic mapping and cloning of genes/mutations that have strong effects on human circadian timing. Less than 20 years after the recognition of these families [1] , we have made great strides into understanding regulatory mechanisms of human sleep behavior. Growing evidence has accumulated over the last 2 decades and revealed that a number of sleep traits in humans are heritable, such as timing of sleep, total daily sleep requirement, response to sleep deprivation, and various EEG measurements/patterns. In these Mendelian sleep phenotypes, single mutations of large effect were shown to be causative for different phenotypes. Therefore, mutations identified using genetics in human families have led to new insights into the detailed molecular mechanisms regulating sleep behavior.
Here, we summarize recent discoveries in the field of human genetics implicating genes in sleep regulation. We will focus primarily on natural variations in sleep traits including the timing, duration and the EEG characteristics of sleep ( Figure 1 ).
Timing of sleep
The timing of sleep is determined by the circadian clock, which is entrained to the environment primarily by light. At a molecular level, the periodicity of biological clocks is generated by transcriptional-translational feedback loops [2] [3] [4] [5] . A growing list of core clock genes have been discovered that encode proteins participating in this feedback loop. Components of the molecular clock are highly conserved in vertebrates [3, 4] . Theoretically, mutations that alter the molecular clock feedback loops may result in altered circadian timing. Indeed, our lab has identified several genetic mutations including casein kinase 1 delta (CK1d) T44A and H46R, period2 (PER2) S662G, period3 (PER3) P415A/H417R and cryptochrome2 (CRY2) A260T from subjects affected by familial advance sleep phase (FASP) ( Table 1 ) (Figure 2 ) [6] [7] [8] 9 ,10 ,11]. Sleep onset and offset times are significantly advanced in individuals with FASP. Most of the mutations characterized to date accelerate the clock and shorten the period, which leads to the advanced phase phenomena [7, 8, 10 ]. In addition, the importance of clock protein post-translation modifications was elucidated by mutations found in PER2 and CK1d [7, 8] . The fact that control of clock protein turnover and stability is critical for sleep regulation is demonstrated repeatedly by studies of PER2, PER3, and CRY2 mutations [7,9 ,10 ]. Each of the mutations found by this approach contributed to a better overall picture of regulatory clock mechanisms.
Importantly, some people who have the strong sleep phase advance phenotype do not carry any mutation in known clock genes (unpublished data). Although mutations in (as yet) unidentified (novel) clock genes may be responsible for this phenotype, other possibilities exist. Altered phase in the setting of a normal core clock may result from altering the connection between the environment and the clock system in the body or the coupling of the core clock to physiological outputs. For example, the light entrainment pathway from retina to SCN may be affected by the potential genetic mutation. Consistent with this hypothesis, circadian and phototransduction genes and pathways were enriched in the recent genome-wide association analysis of self-reported morning-ness [12, 13 ] . Therefore, discovery and study of such novel genes with more intensive genetic tools promise to be fruitful.
Duration of sleep
The duration of sleep and response to sleep loss varies among individuals. We are particularly interested in a cohort of individuals known as Natural Short-Sleepers (NSS). These people sleep significantly less than the Schematic diagram of the known FASP mutations found in humans. PER2 and CRY2 are core clock components and their protein levels are tightly regulated in a circadian manner to ensure stable clock oscillation. All mutations discovered to date impact the protein levels of these two critical core clock components. The PER2 S662G mutation results in hypophosphorylated of PER2 by casein kinase I (CKI), which in turn causes both increased repressor activity and decreased protein stability. Consistent with this theme, two CK1d mutations (T44A and H46R) were found to decrease its enzyme activity for substrates including the PER2 S662 site. Thus, these mutations also lead to altered transcription repressor activity and protein stability of PER2. Another FASP mutations, PER3normal population. Moreover, this phenotype is heritable in some families. Importantly, unlike the patients suffering from sleep disorders, Natural Short-Sleepers are often healthy and free of any apparent detrimental consequence caused by short sleep duration. Previously, we identified a mutation (P384R) in the basic helix-loop-helix family member e41 (BHLHE41or DEC2) gene that is associated with a human familial natural short sleep phenotype (FNSS) [14] . The habitual self-reported total sleep time (average 6.25 hours) for affected individuals per day was much shorter than the non-carrier controls (average 8.06 hours). Mouse models carrying the exact human mutation largely recapture the short sleep phenotype, further confirming the causative role of the mutation [14] . An independent study from another human cohort found other DEC2 missense mutations. One DEC2 mutation (Y362H) occurred in one member of a fraternal twin pair who slept one hour less and showed more resistance to sleep deprivation than his mutation-negative twin. The second mutation, identified in three unrelated individuals, resulted in a glutamine (rather than arginine, P384N) substitution at the same codon as our finding, but led to no obvious phenotype [15 ] . At the molecular level, Y362H and P384R, but not P384N, reduced the ability of DEC2 to suppress CLOCK/BMAL1 transactivation, which suggested a possible underlying mechanism [14, 15 ]. Together, these findings highlight the role of the DEC2 gene in regulation of human sleep duration.
Although several other intriguing candidate genes have been identified, statistical and functional evidence is lacking for many implicated cases [16] [17] [18] [19] . Interestingly, ion-channel genes have been shown to regulate duration of sleep or sleep-like behavior in model organisms [20 ,21,22] , though it is still unclear whether such genes also regulate sleep duration in humans. A plausible case was the ATP-binding cassette sub-family C member 9 (ABCC9) gene which encodes a pore-forming subunit of an ATPsensitive potassium channel, but the SNPs found by different studies were all intronic [16, 17, 23] .
Recent report from the UK Biobank study suggested two association polymorphisms for sleep duration [13 ] . One of the polymorphisms is located upstream and the other downstream of the Vaccinia Related Kinase 2 gene. Although intriguing, further validation by both in vitro and in vivo characterizations of these polymorphisms are needed to confirm their roles in sleep duration.
Characteristics of EEG (electroencephalogram) during sleep
The architecture of sleep is defined by EEG based parameters. Although not fully confirmed, it is believed that some characteristics of EEG may reflect the quality or efficiency of sleep. The features of EEG can also be modulated by the genes that regulate the duration and timing of sleep (Table 1) . One example is the DEC2 gene mentioned above. DEC2 Y362H mutation carriers showed higher delta power during NREM and less REM sleep compared to the non-carriers [15 ] . Another example is a polymorphism in PER3 that also influences EEG variability. This polymorphism is a 54-nucleotide variable number tandem repeat (VNTR) in exon 18 of PER3 that encodes 18 amino acids. Approximately 10% of the population is homozygous for the 5-repeat allele PER3 5/5 [24] . EEG slow wave activity in NREM sleep, theta and alpha activity during wakefulness, and REM sleep were all increased in PER3 5/5 compared to PER3 4/4 individuals [25] . In another study of older subjects (55-75 years), PER3 5/5 carriers also showed increased EEG frontal delta activity and decreased EEG frontal sigma activity during NREM sleep compared with PER3 4/4 subjects [26] . Furthermore, sleep deprived PER3 5/5 individuals had elevated sleep homeostatic pressure as measured, physiologically, by EEG slow-wave energy, and showed a greater detrimental impact of sleep deprivation [24, 25, 27, 28] . Thus, different genetic alterations of the PER3 gene give rise to different effects on human sleep. Recent studies also suggested a possible role for PER3 in mood regulation, which provides the first direct molecular genetic evidence for the long suspected connection between sleep and mood [9 ,29-31] . It will be of interest to probe whether (and how) PER3 serves as a nexus for sleep and mood regulation.
The neuromodulator adenosine is known to contribute to sleep homeostasis [32] . A genetic variant of adenosine deaminase (ADA) D8N, which is associated with the reduced metabolism of adenosine to inosine, specifically enhances deep sleep and SWA during sleep [33, 34] . A larger population-based study corroborated some findings that variant carriers have a deeper sleep and are under higher sleep pressure although other details were not identical [35] . In addition, a distinct polymorphism of adenosine A2A receptor (ADORA2A), which occurred in the 3 0 UTR region and changed the expression level of this gene, affected EEG during sleep and wakefulness in a non-state-specific manner [33] .
Another example is the brain-derived neurotrophic factor (BDNF) gene. A V66M mutation in the encoded protein is linked to impairment of dendritic trafficking and synaptic localization of BDNF and a reduced activity-dependent BDNF secretion [36] . Mutation carriers showed reduced SWS [37] and decreased spectral power in specific bands at different stages of NREM sleep [38] . Thus, BDNF is likely to modulate the electrical activity of the brain, predicting the inter-individual variation of sleep EEG parameters.
Perspectives on human genetics in sleep studies
We have focused here on normal variants of human circadian timing and total sleep requirement. These are not diseases per se. Some individuals find it troublesome to wake up in the early morning hours while others feel virtuous for getting up early. Separate from this, there are many primary sleep disorders like restless leg syndrome, obstructive sleep apnea or narcolepsy. In addition, sleep problems also are seen in many disorders that lead to abnormal brain development or degeneration of normal brain. For example, autism spectrum disorder (ASD) is a neurodevelopmental disorder with evidence for strong genetic susceptibility and a high prevalence of insomnia [39] . Defects in synaptic pruning during the development of neural circuits disrupt the excitatory/inhibitory balance of synapses, which may underlie the atypical neurodevelopment in ASD [40] . Thus, it is intriguing to consider whether sleep problems exacerbate atypical synaptic pruning or if severe neurodevelopmental problem leads to sleep disorders in ASD. Another example is Alzheimer's disease (AD). Most patients with AD have severe sleep problems but recent evidence suggests that sleep disruption is a major contributing factor to AD. Ab plaques, the hallmark of AD, are formed by Ab accumulation. The level of Ab in brain interstitial space is high while awake and lowest upon awakening from a night of sleep [41, 42] . Importantly, sleep disruption abolishes this Ab reduction, suggesting a neurotoxin clearance function for sleep [43] . These examples highlight the importance of understanding the regulatory mechanisms of sleep and sleep functions. Although much remains to be learned about sleep abnormalities in people with brain disorders, it is likely the case that in general, brain dysfunction leads to alterations in sleep. At the same time, chronic sleep deprivation or desynchrony of the clock from the solar day contributes to development or progression of brain disorders.
One issue for many sleep studies conducted in humans is the use of self-reported phenotypes like sleep duration, timing, etc. Several environmental factors such as drugs, seasonal cycle, modern lifestyle and even lunar cycle may affect human sleep [44] [45] [46] . Such factors are not easily controlled and can confound phenotyping. Usually, genetic association studies only provide suggestions that the disease could result from an interaction of environmental factors on a susceptible genetic background. Thus, introducing the genetic mutations into laboratory-housed animals is a powerful approach to test the contribution of a gene to a phenotype. Moreover, in contrast to many well established model organisms, the human population is genetically more heterogeneous, which adds another layer of complexity. In recent years, we and others have mainly focused on single-gene phenotypes, especially those where mutations have dominant effects. However, mutant alleles that segregate as autosomal dominant traits must have a large enough effect to arise on a heterogeneous genetic background. These families with FASP and FNSS are in the 'tails' of the normal distributions in general human populations.
We speculate that most of the variation in the middle of the normal distribution for human sleep phenotypes results from a combination of many genetic variants of small effect that, together, contribute to each individual's unique phenotype. More extensive sequencing efforts for exomes or whole genomes in large populations of individuals representing the spectrum of human phenotypes will be necessary to address this hypothesis.
Conclusion
Here we have summarized published genetic mutations discovered to affect the timing, duration and EEG features of human sleep behaviors. Today, the sleep field has expanded its focus from mammalian model organisms to Drosophila, zebrafish, and even worms [47] . Genetic tools in these systems have allowed researchers to undertake large-scale screens to identify new genes for regulation of sleep-like behavior. Such progress has further provided opportunities to probe sleep circuitry and sleep function on a molecular level. Nonetheless, due to the large variation of sleep characteristics among different species and the unique features of human sleep, human genetics will continue to be an indispensable and invaluable source of insight providing critical information on this mysterious phenomenon-sleep.
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